Center for Veterinary Medicine
Spacer
Spacer
Spacer

Search

Powered by Google


" "

Table of Contents

About CVM Red bullet
Mission Statement
Red bullet
CVM Organization Chart Red bullet
Vision Statement Red bullet
Guiding Principles Red bullet
Introduction Red bullet
A Brief History of CVM Red bullet
Structure/ Responsibility Red bullet
CVM Annual Reports Red bullet
Safeguarding Animal HlthRed bullet
Office of the Director (OD) Red bullet
Mgmt & Communications Red bullet
CVM & Budget Red bullet
Ofc of New Animal Drug Red bullet
Surveillance/Compliance Red bullet
Office of Research Red bullet

Spacer Spacer
Office of the Director

The Federal Food, Drug, and Cosmetic Act allows the Secretary of Health and Human Services to delegate his or her authority to others, such as the Commissioner of Food and Drugs. The Commissioner has redelegated his or her authority for a number of functions to CVM. Among these redelegated functions are:

  • Authority to approve New Animal Drug Applications and their supplements and Abbreviated New Animal Drug Applications (for generic drugs).

  • Authority to issue proposals, notices, and orders relating to refusal to approve and withdrawal of approval of New Animal Drug Applications and corresponding new animal drug regulations.

  • Authority to approve the use of certain food additives.

The functions of the Office of the Director are as follows:

  • Directs overall Center activities and coordinates and establishes Center policy in the areas of research, management, scientific evaluation, compliance, and surveillance.

  • Directs systems for planning, programming, and budgeting and provides administrative and information support for the Center.

  • Plans and coordinates the Center's Equal Employment Opportunity Program.

  • Approves New Animal Drug Applications (NADAs) and Abbreviated New Animal Drug Applications (ANADAs), and issues notices of withdrawal of new animal drug approvals when opportunities for hearings have been waived.

  • Authorizes, for use as edible products, animals treated with investigational drugs and terminates exemptions for investigational trials.

  • Approves the use of animal food additives.

  • Ensures that industry submitted NADAs for food-producing animals are reviewed and evaluated with respect to possible effects on human health. The Director also serves as the Center's representative and spokesperson concerning CVM activities. The Director's contacts include the general public, industry, other government agencies, and national and international organizations.

Red bulletCVM Ombudsman

CVM Update

Dr. Tollefson Promoted to Rear Admiral 8/16/01


Updated August 17, 2001 at 11:00 PM ET

www dot healthfinder dot gov Link to FirstGov




Spacer
Spacer
horizonal rule
FDA Logo links to FDA home page HHS Logo links to Department of Health and Human Services website U.S. Food and Drug Administration Center for Veterinary Medicine FDAMA Antimicrobial Resistance Biotechnology Aquaculture Food Safety BSE Guidance Documents Green Book Freedom of Information link to the FDAMA page link to the Antimicrobial Resistance page link to the Biotechnology page link to the Aquaculture page link to the Food Safety page libk to the BSE page link to the Guidance Documents page link to the Green Book page link to the Freedom of Information page